Chagas disease and blood transfusion: An emerging issue in non-endemic countries;Maladie de Chagas et transfusion sanguine: Un problème parasitaire émergent dans lespays non endémiques

Transfusion Clinique et Biologique

Volumn 18, Issue 2, 2011, Pages 286-291

  Assal, A ^a   Corbi, C ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Chagas disease; Screening; Transfusion; Trypanosoma cruzi

Indexed keywords

PARASITE ANTIBODY; RECOMBINANT ANTIGEN; TRYPANOSOMA CRUZI ANTIBODY; UNCLASSIFIED DRUG;

BLOOD DONOR; BLOOD TRANSFUSION; CHAGAS DISEASE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FRANCE; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; IMMIGRATION; IMMUNOFLUORESCENCE TEST; NEUROLOGIC DISEASE; PARASITE TRANSMISSION; REDUVIIDAE; SCREENING; SEROPREVALENCE; SHORT SURVEY; TRYPANOSOMA CRUZI;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; CHAGAS DISEASE; DONOR SELECTION; EMIGRANTS AND IMMIGRANTS; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FRANCE; HUMANS; LATIN AMERICA; MATERNAL EXPOSURE; PARASITEMIA; RECOMBINANT PROTEINS; SEROEPIDEMIOLOGIC STUDIES; TRAVEL; TRYPANOSOMA CRUZI;

EID: 79954631049     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2011.02.006     Document Type: Short Survey

References (22)

1. WHO Expert Committee on the Control of Chagas Disease (2000: Brasilia, Brazil). Control of Chagas Disease; second report of the WHO Expert Committee 2002. WHO technical reports series, 905. Geneva: World Health Organization (WHO), 2002. 109 p. Disponible sur (accès le 9/2/2011). http://whqlibdoc.who.int/trs/WHO_TRS_905.pdf.
2. Pelloux H., Aznar C., Bouteille B. Trypanosomiases. Rev Prat 2006, 56:2209-2216.
3. Grant I.H., Gold J.W., Wittner M., Tanowitz H.B., Nathan C., Mayer K., et al. Transfusion- associated acute Chagas disease acquired in the United States. Ann Intern Med 1989, 111:849-851.
4. Nickerson P, Orr P, Schroeder ML, Sekla L, Johnston JB. Transfusion- associated Trypanosoma cruzi infection in a non endemic area. Ann Intern Med 1989;111:851-3.
5. Villalba R., Fornés G., Alvarez M.A., Román J., Rubio V., Fernández M., et al. Acute Chagas disease in a recipient of bone marrow transplant in Spain: case report. Clin Infect Dis 1992, 14:594-595.
6. Leiby D.A., Lenes B.A., Tibbals M.A., Tames-Olmedo M.T. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999, 341:1237-1239.
7. Lane D.J., Sher G., Ward B., Ndao M., Leiby D., Hewlett B. Investigation of the second case of transfusion transmitted Chagas disease in Canada. Blood 2000, 96:60a.
8. Youg C., Losikoff P., Chawla A., Glasser L., Forman E. Transfusion-aquired Trypanosoma cruzi infection. Transfusion 2007, 47:540-544.
9. Fores R., Sanjuan I., Portero F., Ruiz E., Regidor C., López-Vélez R., et al. Chagas disease in a recipient of cord blood transfusion. Bone Marrow Transplant 2007, 39:127-128.
10. Flores-Cháves M., Fernández B., Puente S., Torres P., Rodríguez M., Monedero C., et al. Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin Infect Dis 2008, 46:e44-47.
11. Schmunis G.A. Epidemiology of chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz, Rio de Janeiro 2007, 102:75-85.
12. Leiby D.A. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of involving donor's demographics on seroprevalence and implication for transfusion transmission. Transfusion 2002, 42:549-555.
13. Organisation mondiale de la santé (OMS). Maladie de Chagas: lutte et élimination. Rapport du secrétariat de la 72e Assemblée mondiale de la santé. 20 mars. A62/17, page 2. Genève: OMS; 2009. Disponible sur: (accès le 9/2/2011). http://apps.who.int/gb/ebwha/pdf_files/A62/A62_17-fr.pdf.
14. Munoz J., Coll O., Juncosa T., Vergés M., del Pino M., Fumado V., et al. Prevalence and vertical transmission of trypanosoma cruzi infection among pregnant lation America women attending two maternity clinics in Barcelona. Spain. Cin Infect Dis 2009, 48:1736-1740.
15. Piron M., Vergés M., Muňoz J., Casamitjana N., Sanz S., Maymó R.M., et al. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 2008, 48:1862-1868.
16. Lescure F.X., Canestri A., Melliez H., Jauréguiberry S., Develoux M., Dorent R., et al. Chagas disease, France. Emerg Infec Dis 2008, 14:644-646.
17. Jackson Y., Gétaz L., Wolff H., Holst M., Mauris A., Tardin A., et al. Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. Plos Negl Trop Dis 2010, 4:e592.
18. Schmunis G.A. Epidemiology of Chagas Disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007, 102:75-85.
19. Milei J., Guerri-Guttenberg R.A., Grana D.R., Storino R. Pronostic impact of Chagas disease in the United States. Ann Heart J 2009, 157:22-29.
20. Salamanca D.D., La Ruche G., Tarantola A., Degail M.A., Jeannel D., Gastellu-Etchegorry M. Maladie de Chagas en France: estimation du nombre de personnes infectées et d'atteintes cardiaques en 2009, selon les groupes à risque. Bull Soc Pathol Exot 2009, 102:285-290.
21. Pirard M., Iihoshi N., Boelaert M., Basanta P., López F., Van der Stuyft P. The validity of serologic tests for Trypanozoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 2005, 45:554-561.
22. Assal A., Aznar C. Chagas disease screening in the French blood donor population. Screening assays and donor selection. Enferm Emerg 2007, 9:36-40.